Creutzfeldt-Jakob
The latest sourced reporting on Creutzfeldt-Jakob from Dementias Today: dated, and plain about what the evidence does and does not show.
University Hospitals Cleveland Medical Center has registered PROSPECT, a natural history study of adults carrying or at risk of PRNP gene mutations, built to capture what happens before symptoms start rather than after death.
Governor Kathy Hochul has signed a law forcing New York's long-term care hotline, NY Connects, to actively point callers toward Alzheimer's and dementia programs rather than leaving them to ask. The catch: nothing changes for a full year.
The Massachusetts House voted unanimously on July 29, 2026 to require acute care hospitals to notify a designated family member or caregiver soon after a dementia patient is admitted and again before discharge. The bill, which also expands diagnosis notification and creates a new MassHealth care coordination benefit, now heads to the Senate.
A regional midterm review of the UN Decade of Healthy Aging finds that the share of countries in the Americas with a national long-term-care policy jumped from 61 percent to 88 percent since 2020, but the money and services to make those policies real have not kept pace, with direct consequences for how dementia care gets funded and staffed.
The National Institute on Aging has published the finalized report from its fourth triennial Dementia Care and Caregiving Research Summit, naming five research areas and a list of gaps it wants filled next, including a fresh estimate that dementia now costs the country up to $800 billion a year.
A peer-reviewed case report describes a Louisiana hunter's fatal, laboratory-confirmed sporadic Creutzfeldt-Jakob disease and the public health investigation triggered when a hunting-lodge peer developed similar illness; investigators found no evidence tying the cases to chronic wasting disease in local deer.
The Public Health Agency of Canada's surveillance dashboard, current to 19 June 2026, reports higher sporadic Creutzfeldt-Jakob disease counts since 2015, and attributes the rise to a more sensitive test rather than to a change in the disease itself.
A new Frontiers in Neuroscience analysis of 17 years of Brazilian Ministry of Health records finds 1,576 suspected Creutzfeldt-Jakob notifications where the authors calculate about 3,200 cases should have occurred. A Mexico City emergency department series points the same way from the opposite direction.
In a mouse study published on 5 February 2026 in the Journal of General Virology, cofactor-free prion protein fibrils induced misfolded protein and spongiform brain damage in knock-in animals carrying the E200K mutation, but not in animals with wild-type prion protein.
Bench work with scrapie-positive sheep tissue finds the inhibition comes from damage to the assay's own protein substrate, not destruction of the prion seeds, and that whole blood is one of the few sample types still near inhibitory levels after a 1,000-fold dilution.
Laboratory work from the MRC Prion Unit at UCL, published in PNAS on 11 June 2026, reports a dividing cell system that propagates variant Creutzfeldt-Jakob disease prions from patient brain while remaining refractory to sporadic CJD isolates. No patients were treated or tested.
A UCL team reports a dividing human-prion cell line, EKV, that keeps sporadic CJD prions growing indefinitely and measures how much infectivity a sample carries in weeks rather than years. It works only for some patients' prions, and it is laboratory work, not treatment.
The agency's guidance for funeral and crematory practitioners, revised 21 January 2026, says classic Creutzfeldt-Jakob disease requires no special interment, entombment, inurnment or cremation, and a UK community policy reissued in March 2026 says isolation is not required at home.
A Spanish pedigree study reported that children of a parent carrying a PRNP mutation inherit it about two thirds of the time. UK and US prion researchers say the recruitment method inflated that number, and the authors have replied.
A PROSPERO-registered systematic review in BMC Palliative Care pooled 30 studies covering 4,434 people with rapidly progressive prion disease. It found the fullest ranking of what is hardest to live with still comes from a 2019 survey of 71 family carers, not from measurement.
A 35-author panel, including a lived-experience representative, has published practical recommendations for Creutzfeldt-Jakob disease in Age and Ageing, with a dedicated section on support for families and professionals.
A retrospective study of 177 US cases from the national prion surveillance centre reports histopathologic differences between codon 129 haplotypes and genotypes, and measures prion seeding levels in frontal cortex. Published in Acta Neuropathologica on 13 January 2026.
A single-country dataset from one of the world's largest E200K clusters reports RT-QuIC sensitivity of 97.4 per cent, while the older markers 14-3-3 and total tau tracked strongly with a patient's codon 129 genotype
The Australian National Creutzfeldt-Jakob Disease Registry's annual surveillance report, published 21 July 2026, shows 44 of 84 initial case notifications for 2025 were still recorded as 'incomplete' at the end of that year, a measure of how long it takes to count a rapidly fatal dementia.
The registration for PRiSM, a phase 1 study sponsored by the Broad Institute and run through the NIH NeuroNEXT network, shows a single intrathecal dose design measuring safety and drug activity, not survival or cognition. The animal work behind it was done in mice.
Xuanwu Hospital in Beijing has registered a 246-patient, 21-centre trial testing whether the antiretroviral can extend survival. The rationale so far rests on prion-infected mice; no human results exist.
The registry record for PrProfile now runs to February 2027 and adds about 20 symptomatic participants on active drug only. No results from the first 56 have been published.
A primate experiment begun in 2009 found no clinical prion disease in monkeys given deer and elk prions. Yet tissue from those apparently healthy animals sickened mice, and then voles, at a 100 percent rate on further passage. Here is what that shows, and what it does not.